{
    "Trade/Device Name(s)": [
        "Liquichek Urine Toxicology Control (Level C1)"
    ],
    "Submitter Information": "Bio-Rad Laboratories",
    "510(k) Number": "K050682",
    "Predicate Device Reference 510(k) Number(s)": [
        "K033404"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "DIF"
    ],
    "Summary Letter Date": "March 10, 2005",
    "Summary Letter Received Date": "March 16, 2005",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.3280"
    ],
    "Regulation Name(s)": [
        "Clinical toxicology control material"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "d-Amphetamine",
        "d-Methamphetamine",
        "Secobarbital",
        "Amobarbital",
        "Butalbital",
        "Pentobarbital",
        "Phenobarbital",
        "Nordiazepam",
        "a-hydroxyalprazolam",
        "11-Nor-\u0394-9-THC-9-COOH",
        "Benzoylecgonine",
        "Ethanol",
        "LSD",
        "Methadone",
        "Methaqualone",
        "Morphine-3-\u03b2-D-glucuronide",
        "Codeine",
        "Phencyclidine",
        "Norpropoxyphene",
        "Creatinine",
        "MDMA",
        "MDA",
        "MDEA",
        "Specific Gravity",
        "pH"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [],
    "Methodologies": [],
    "Submission Type(s)": [
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for Bio-Rad Liquichek Urine Toxicology Control (Level C1) as a quality control urine for laboratory toxicology procedures.",
    "Indications for Use Summary": "Intended for use as quality control urine to monitor the performance of laboratory urine toxicology confirmatory procedures.",
    "fda_folder": "Toxicology"
}